Lung Cancer Screening: Do You Qualify, and What Happens Next

Most people have heard of mammograms and colonoscopies. Far fewer know that there's a screening test for lung cancer, even though lung cancer kills more people in the United States than breast, colon, and prostate cancer combined. The reason it's less familiar is partly timing: the test only became a formal recommendation in 2013, and the criteria for who should get it have shifted since then. If you have a significant smoking history, it's worth knowing whether you qualify, because this is one of the few cancer screenings with solid trial evidence behind it.

Who actually qualifies for screening

The U.S. Preventive Services Task Force (USPSTF) recommends annual low-dose CT screening for adults who meet all three of these conditions: you're between 50 and 80 years old, you have at least a 20 pack-year smoking history, and you currently smoke or quit within the past 15 years (USPSTF, 2021).

A pack-year is a pack a day for a year, so 20 pack-years could mean a pack a day for 20 years, two packs a day for 10 years, or any combination that adds up. If you're not sure how your history adds up, that's a normal thing to walk through on a visit rather than calculate on your own.

Two details trip people up. First, screening stops being recommended once you've been smoke-free for more than 15 years, since the excess risk from smoking declines steadily after quitting. Second, the guideline doesn't currently extend to people who have never smoked, even those with other risk factors like radon or family history, because the trial evidence doesn't cover that group well. If you fall outside the criteria but you're still worried about your risk, that concern is worth raising directly, since individual risk calculators and clinical judgment sometimes change the picture.

What the scan involves, and what it doesn't

The test is a low-dose CT (LDCT) scan of the chest, done once a year if you keep meeting the criteria. It's not a blood test and it's not something a telehealth visit can perform directly, since it requires imaging equipment. What a primary care visit can do is confirm you qualify, order the scan at an imaging center near you, and walk through the results together afterward.

The scan takes about 10 minutes, doesn't require contrast dye, and the radiation dose is substantially lower than a standard diagnostic chest CT. The two major trials behind this recommendation, the National Lung Screening Trial in the U.S. and the NELSON trial in Europe, both found that annual low-dose CT screening reduced lung cancer deaths compared to no organized screening, or in the NLST's case, compared to chest X-ray (National Lung Screening Trial Research Team, 2011; de Koning et al., 2020). That's the kind of hard mortality outcome that doesn't exist for a lot of other screening tests still in wide use.

What a nodule on your scan does and doesn't mean

Most people who get screened don't have cancer, but it's common for a scan to turn up a small nodule, a tiny spot on the lung that needs a closer look. This happens often enough that radiologists use a standardized system (Lung-RADS) to grade how concerning a nodule looks and recommend next steps, which usually means repeating the scan in 3 to 12 months to see if it's grown.

A nodule showing up is unsettling, but in the large majority of cases it turns out to be scar tissue, an old infection, or something else unrelated to cancer. The point of the follow-up protocol is to tell the difference without rushing to biopsy something that doesn't need one. If your scan finds something, expect a conversation about what the grade means and what the follow-up timeline looks like, not an automatic referral for an invasive procedure.

The real tradeoffs worth knowing

No screening test is free of downsides, and lung cancer screening has a few worth naming honestly. False positives are common enough that you should expect some scans to come back with findings that need monitoring rather than a clean "all clear." Radiation exposure, while low per scan, accumulates with annual testing over years. And occasionally a biopsy gets done on something that turns out to be benign, which carries its own small procedural risk.

The USPSTF weighed these tradeoffs against the mortality benefit and still recommends annual screening for the eligible group, which tells you the benefit outweighs the harms for people who actually meet the criteria. It does not mean the test is risk-free, and it's part of why screening isn't recommended for people outside the eligible age and smoking-history range, where the potential harms would outweigh a much smaller expected benefit.

Quitting still does more than any scan

Screening finds cancer earlier. It does not prevent it. The single biggest thing you can do to lower your lung cancer risk is to stop smoking, and the benefit starts accumulating almost immediately after you quit (CDC, Lung Cancer Screening). If you currently smoke, a screening conversation is also a reasonable moment to talk through quitting support, whether that's nicotine replacement, prescription medication, or a structured program, since combining screening with cessation support gives you more benefit than either one alone.

It's also worth saying plainly: screening and quitting aren't substitutes for each other. A clean scan this year doesn't offset ongoing smoking, and quitting doesn't mean you can skip screening if you still meet the eligibility window. They're two separate, additive things you can do.

Getting screened

If you're between 50 and 80 with a significant smoking history, it's worth a conversation about whether you qualify and, if so, getting your first scan ordered. We can review your smoking history, confirm eligibility against current guidelines, order the low-dose CT at an imaging center near you, and go over the results together. Primary care visits are available by telehealth appointment, and most major insurance plans are accepted, including Medicare.